Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
UnitedHealthcare Group Inc.
January 22, 2026 6:58 AM 3 min read

UnitedHealth CEO Says Hospitals, Drug Prices Drive US Health Care Costs, Pledges ACA Rebates

by Vandana Singh Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Stephen Hemsley, chairman and CEO of UnitedHealth Group (NYSE:UNH), told lawmakers that rising hospital prices, consolidation, specialty services, and prescription drug costs—not insurers—are the primary forces pushing U.S. health care spending higher. He urged policy reforms to improve affordability and access.

Hemsley, alongside executives from Cigna Group (NYSE:CI), Elevance Health Inc. (NYSE:ELV), and CVS Health Corp. (NYSE:CVS), will be appearing before two House panels on Thursday.

Premium rates are based on two key factors: how much care is used and how much is charged for that care. When the price of care goes up, and care activity increases, the cost of health coverage necessarily follows, he added.

Background

A Senate Judiciary Committee investigation already found that UnitedHealth used aggressive strategies to collect diagnoses that increased federal payments under Medicare Advantage.

According to the Senate report, UnitedHealth transformed that payment adjustment process into a profit driver, a use that investigators said went beyond the program's original intent.

Hemsley said UnitedHealth serves nearly 10 million Medicare Advantage members, about one million Affordable Care Act exchange enrollees, and Medicaid beneficiaries across 32 states.

"Though UnitedHealthcare is a relatively small participant in the individual ACA market, we will voluntarily eliminate and rebate our profits this year for these coverages," Hemsley said in the prepared testimony.

The testimony didn't provide details on UnitedHealth's rebate plan or what the financial impacts may be.

Bloomberg highlighted that the decision from UnitedHealth, the largest U.S. health insurer, could neutralize accusations that it's unduly profiting from taxpayer-funded help.

Hemsley said UnitedHealth negotiated nearly $300 billion in discounts last year and saved about $35 billion through fraud and waste reduction.

He argued that value-based care and Medicare Advantage models deliver better outcomes at lower costs, citing fewer hospital admissions and improved chronic disease management.

Policy Changes

The CEO urged Congress to consider policy changes, including site-neutral payments, patent reform, limits on direct-to-consumer drug advertising, and expanded consumer choice in ACA plans, saying collaboration across the system is essential to making care more affordable.

Hemsley on Wednesday added that policymakers should also consider standardizing ACA broker compensation, as that creates incentives to steer patients toward plans that pay higher commissions. Standardization is the norm in Medicare Advantage, by comparison, he said.

"Standardizing compensation would better align broker incentives with consumer interests, promote more objective plan selection, and help consumers choose coverage based on value, affordability, and access to care rather than commission differentials," Hemsley said.

In January, UnitedHealth said it is launching a pilot program aimed at accelerating Medicare Advantage payments for rural hospitals.

UNH Price Action: UnitedHealth Group shares were down 0.50% at $346.00 during premarket trading on Thursday, according to Benzinga Pro data.

Image via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
Large CapNewsHealth CareLegalTop StoriesGeneralExpert IdeasStories That Matter
UNH Logo
UNHUnitedHealth Group Inc
$291.20-0.37%
Overview
CI Logo
CIThe Cigna Group
$271.340.03%
CVS Logo
CVSCVS Health Corp
$74.21-0.31%
ELV Logo
ELVElevance Health Inc
$337.67-2.68%

In a prepared testimony before the House Energy and Commerce Subcommittee on Health on Wednesday, Hemsley said the health care system is "not as good as it should be," acknowledging shared responsibility while emphasizing insurers' role in restraining costs through negotiations, care coordination, and preventive care.

The Rural Payment Acceleration Pilot aims to reduce payment collection times for rural hospitals by 50%, from less than 30 days to under 15 days. This six-month pilot will provide immediate cash-flow relief to independent rural hospitals in states like Oklahoma, Idaho, Minnesota, and Missouri.

UNH Logo
UNHUnitedHealth Group Inc
$291.20-0.37%
Overview
CI Logo
CIThe Cigna Group
$271.340.03%
CVS Logo
CVSCVS Health Corp
$74.21-0.31%
ELV Logo
ELVElevance Health Inc
$337.67-2.68%
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...